Evidence map›Paper›PMID 27211562›Full record

ArticleEBioMedicine2016

Phenotypically distinct subtypes of psychosis accompany novel or rare variants in four different signaling genes.

Thorsten M Kranz, Adam Berns, Jerry Shields, Karen Rothman, Julie Walsh-Messinger, Raymond R Goetz, Moses V Chao, Dolores Malaspina

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Aberrant triple-network connectivity patterns discriminate biotypes of first-episode medication-naive schizophrenia in two large independent cohorts.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  10. Review
  11. Article
  12. Regulation of BDNF Release by ARMS/Kidins220 through Modulation of Synaptotagmin-IV Levels.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Thorsten M KranzSkirball Institute of Biomolecular Medicine, Departments of Cell Biology, Physiology & Neuroscience and Psychiatry, New York University, NY, NY 10016, USA. Electronic address: Thorsten.kranz@nyumc.org.
Adam BernsInstitute for Social and Psychiatric Initiatives (InSPIRES), Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA. Electronic address: Adam.berns@med.nyu.edu.
Jerry ShieldsInstitute for Social and Psychiatric Initiatives (InSPIRES), Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA. Electronic address: jeshields@chpnet.org.
Karen RothmanInstitute for Social and Psychiatric Initiatives (InSPIRES), Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA. Electronic address: Karen.rothman@nyumc.org.
Julie Walsh-MessingerUniversity of Dayton, Department of Psychology, Dayton, OH, USA. Electronic address: jmessinger1@udayton.edu.
Raymond R GoetzNew York State Psychiatric Institute, Division of Clinical Phenomenology, 1051 Riverside Drive, New York, NY 10032, USA. Electronic address: Goetzra@nyspi.columbia.edu.
Moses V ChaoSkirball Institute of Biomolecular Medicine, Departments of Cell Biology, Physiology & Neuroscience and Psychiatry, New York University, NY, NY 10016, USA. Electronic address: Moses.chao@med.nyu.edu.
Dolores MalaspinaInstitute for Social and Psychiatric Initiatives (InSPIRES), Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA. Electronic address: Dolores.malaspina@nyumc.org.
New York University · USInspire Institute · USNew York State Psychiatric InstituteUniversity of Dayton · US

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
Institutional Clinical and Translational Science AwardUL1TR000038 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL, HOCHMAN, JUDITH S · 2012 to 2014
$16.8M
Mechanisms of BDNF and Glucocorticoid ActionR01MH086651 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHAO, MOSES VICTOR, GARABEDIAN, MICHAEL J. · 2009 to 2013
$3.1M
Mentoring Translational Schizophrenia ResearchersK24MH001699 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MALASPINA, DOLORES · 2000 to 2009
$1.3M
Paternal Age Related Schizophrenia as a Discrete DisorderRC1MH088843 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MALASPINA, DOLORES · 2009 to 2010
$979k
Molecular Analysis of Neurotrophin ActionR56NS021072 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHAO, MOSES VICTOR · 2011 to 2017
$882k
NCATS NIH HHS UL1 TR000038NCATS NIH HHS UL1 TR001445NIMH NIH HHS K24 MH001699NIMH NIH HHS R01 MH086651NIMH NIH HHS RC1 MH088843NINDS NIH HHS R56 NS021072
6 · The paper itself

Abstract

backgroundRare gene variants are important sources of schizophrenia vulnerability that likely interact with polygenic susceptibility loci. This study examined if novel or rare missense coding variants in any of four different signaling genes in sporadic schizophrenia cases were associated with clinical phenotypes in an exceptionally well-characterized sample.

methodStructured interviews, cognition, symptoms and life course features were assessed in 48 ethnically-diverse cases with psychosis who underwent targeted exome sequencing of PTPRG (Protein Tyrosine Phosphatase, Receptor Type G), SLC39A13 (Solute Carrier Family 39 (Zinc Transporter) Member 13), TGM5 (transglutaminase 5) and ARMS/KIDINS220 (Ankyrin repeat-rich membrane spanning protein or Kinase D-Interacting Substrate of 220kDa). Cases harboring rare missense coding polymorphisms or novel mutations in one or more of these genes were compared to other cases not carrying any rare missense coding polymorphisms or novel mutations in these genes and healthy controls.

findingsFifteen of 48 cases (31.25%) carried rare or novel missense coding variants in one or more of these genes. The subgroups significantly differed in important features, including specific working memory deficits for PTPRG (n=5); severe negative symptoms, global cognitive deficits and poor educational attainment, suggesting a developmental disorder, for SLC39A13 (n=4); slow processing speed, childhood attention deficit disorder and milder symptoms for TGM5 (n=4); and global cognitive deficits with good educational attainment suggesting neurodegeneration for ARMS/KIDINS220 (n=5). Case vignettes are included in the appendix.

interpretationGenes prone to missense coding polymorphisms and/or mutations in sporadic cases may highlight influential genes for psychosis and illuminate heterogeneous pathways to schizophrenia. Ethnicity appears less important at the level of genetic variability. The sequence variations that potentially alter the function of specific genes or their signaling partners may contribute to particular subtypes of psychosis. This approach may be applicable to other complex disorders.

Indexed as

MutationAdultCation Transport ProteinsExomeFemaleGenetic Predisposition to DiseaseHumansMaleMembrane ProteinsMiddle AgedNerve Tissue ProteinsPsychotic DisordersReceptor-Like Protein Tyrosine Phosphatases, Class 5SchizophreniaSequence Analysis, DNASignal TransductionCation Transport ProteinsKIDINS220 protein, humanMembrane ProteinsNerve Tissue ProteinsPTPRG protein, humanReceptor-Like Protein Tyrosine Phosphatases, Class 5SLC39A13 protein, humantransglutaminase 5TransglutaminasesARMS/KIDINS220DiagnosisEndophenotypeHuman geneticsNeurotrophinsPsychosisSchizophrenia

Identifiers

PMID27211562
PMCPMC4856793
OpenAlexW2298668929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.